Approximately 20% of patients with recurring seizures have focal drug-resistant epilepsy. It remains challenging to localize the epileptogenic zone (EZ), defined as the region of brain that must be resected or modulated to obtain seizure freedom. No precise localization for the EZ is currently available, and the seizure onset zone remains the gold standard for defining the EZ. Low Frequency EEG Activity (LFA) is relatively understudied and prior data suggests that LFA can improve EZ localization. This proposal?s objective is to fully evaluate the potential of LFA for EZ localization and to clarify pathophysiologic mechanisms that underlie LFA. To this end, a retrospective analysis of 94 patients will examine the potentially efficacy of LFA for estimating the EZ, and a cohort of 40 patients will be prospectively enrolled for more detailed assessments. Clinical outcomes from treated patients will be used to retrospectively determine the EZ, which can be used to evaluate the EZ as estimated by LFA. Prospective patients will receive simultaneous recordings from clinical EEG macroelectrodes as well as from research-grade microelectrodes, which record neuronal units using DC- capable amplifiers. In addition, cutting edge techniques for magnetic resonance spectroscopy will be used to determine neurotransmitter levels for these same brain regions. Finally, non-invasive high density EEG in conjunction with invasive EEG will be used to assess the potential for non-invasive estimation of the EZ. We expect that this proposal will lead to more accurate non-invasive and invasive localization of the EZ, which would lead to improved patient outcomes. Understanding the mechanisms underlying LFA will improve biomarker development and application to clinical use and could influence treatment-related decisions. An informative EEG biomarker based on LFA from non-invasive evaluations means patients could potentially avoid invasive EEG monitoring. For this mentored award, the career plan includes the overall goal of independence as a clinician investigator studying epilepsy with the following training objectives: (1) learn about study design for human research, (2) obtain formal instruction in informatics and biostatistics, (3) understand biomarker development, (4) learn about microelectrode recordings and MR spectroscopy, (5) improve grant writing skills, (6) develop relationships with extramural researchers, and (7) maintain and improve awareness of current literature. The environment for career development includes a multidisciplinary team including epilepsy, neuroradiology, and biostatistics with prior lab experience and support in microelectrode recordings and EEG biomarker development.

Public Health Relevance

Finding the precise brain location that generates seizures remains challenging. This research proposes using low frequency brain waves to help localize the brain region responsible for seizure generation, and combines data from clinical and research electrodes as well as advanced neuroimaging techniques to better understand how this region differs from other brain regions. These results could minimize the time that patients undergo invasive brain wave monitoring or, in some cases, mean that patients avoid invasive monitoring altogether.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23NS112339-02
Application #
9964928
Study Section
NST-2 Subcommittee (NST)
Program Officer
Whittemore, Vicky R
Project Start
2019-07-01
Project End
2024-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905